Our results demonstrated that up-regulation of CUEDC2 decreases proliferation of lung adenocarcinoma cells, by inhibiting the PI3K-Akt transduction pathway and concomitant p21 up-regulation and cyclin D1 down-regulation. The gene discussed is AKT1; the disease is lung adenocarcinoma.